Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

Kale Kundert, James E Lucas, Kyle E Watters, Christof Fellmann, Andrew H Ng, Benjamin M Heineike, Christina M Fitzsimmons, Benjamin L Oakes, David F Savage, Hana El-Samad, Jennifer A Doudna, Tanja Kortemme

Preprint posted on May 15, 2018

A recent preprint highlights an advance in CRISPR/Cas9 technology that would enable the independent regulation of different target genes in the same cell.

Selected by Samantha Seah


Utilising ligands to activate or deactivate sgRNAs provides a new way to regulate CRISPR-Cas9 activity in a dose-dependent manner, enabling manipulations to be carried out on different targets within the same cell.



The CRISPR/Cas9 system almost needs no introduction – its ease of use has made it the most attractive system for genetic engineering today. The Cas9 nuclease is targeted to specific sites in the genome by the introduction of single guide RNAs (sgRNAs) complementary to the site of interest, enabling precise DNA cleavage that can be utilised to generate gene knockouts or knock-ins. Alternatively, the inactivation of both Cas9 nuclease domains and coupling to an enzymatic domain, such as to an activation domain or epigenetic modifier, enables the specific targeting of enzymatic activities to exact genomic coordinates. Similarly, the inactivated Cas9 protein (dCas9) is able to sterically repress transcription.  Previous adaptations made to control CRISPR/Cas9 activity largely target Cas9 activity using chemical or optical inputs, which modulates all gene targets in the same direction. It is also possible to use multiple orthogonal CRISPR-Cas9 systems to modulate different targets in different directions. A key limitation of the CRISPR/Cas technology is the potential for off-target effects, which may introduce unwanted effects and limits the use of CRISPR-Cas9 in therapeutics.


Key Findings

The authors demonstrate the use of ligands to activate or deactivate sgRNA, and thus CRISPR/Cas9. This was carried out by the addition of ligand-binding aptamers to the sgRNAs utilised. By choosing to target sgRNAs, which vary between different targets, different manipulations can be carried out on different targets within the same cell.

Here, the authors chose to use the well-characterised small molecule, theophylline, and its corresponding aptamer, to establish the system. They tested three different strategies to link the aptamer to sgRNA, and eventually found that strand displacement, using sequences that enable alternative base pairing in the ligand-bound and ligand-free states, was most successful strategy. Multiple designs were responsive to theophylline in vitro, and these included designs that were activated or deactivated by the addition of theophylline. Utilising CRISPR-Cas9-mediated repression of fluorescent protein expression, they showed that the ligand-activated and inactivated sgRNAs had up to 11x and 13x dynamic ranges respectively, spanning over 50% of the range achieved by the controls. These sgRNAs also responded to changing concentrations of theophylline in a dose-dependent manner, suggesting that these sgRNAs could be used to precisely modulate gene expression.

The authors even utilised a second, related ligand-aptamer pair. The 3-methylxanthine (3mx) aptamer differs from that of theophylline by a single base-pair, and even as the theophylline aptamer is recognised by both ligands, the 3-methylxanthine aptamer only responds to its ligand, 3mx. They were then able to establish a system with two different fluorescent proteins under the control of different ligand-aptamer pairs, and demonstrated that fluorescent protein expression can be logically and temporally regulated by sequential addition and removal of the two ligands.

Figure 1a from the preprint: Principles of the technology. Small molecule aptamers are inserted into sgRNAs, resulting in the stabilisation of functional CRISPR-Cas9-sgRNA complexes either in the presence (above) or absence (below) of the ligand.


What I like about this work

I find the principles of this modification of CRISPR/Cas9 technology extremely elegant. By regulating individual sgRNAs, target genes can be independently modulated. The fact that they found both ligand activated and deactivated sgRNAs suggests that different genes can be regulated in opposite directions with a single ligand.



The authors have established this system in bacteria cells, and it would be interesting to see if similar systems could be adapted for use in mammalian cells. The authors attempted this in both yeast and mammalian systems, and it did not appear to convincingly work in either. In addition, higher concentrations of theophylline was toxic to mammalian cells. It appears that alternative ligand-aptamer systems might be required to transfer this technology into eukaryotic cells.

(To the authors: Do you have any idea why the system did not appear to work in the eukaryotic cells tested? Do you have any idea how you might overcome this, to transfer the technology into eukaryotic cells?)

In addition, the availability of a variety of ligand-aptamer pairs that can act independently of each other would be ideal. Scientists could then pick and test ligand-aptamer pairs that suit their purposes.

Off-target effects are often problematic in CRISPR/Cas9 applications, and one way to minimise off-target effects is to only have Cas9 expressed for extremely short time periods. It would be interesting to see if this technology could be coupled with transient transfection to further minimise off-target effects.

Tags: crispr-cas, crispri

Posted on: 14th June 2018

Read preprint (No Ratings Yet)

  • Have your say

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Sign up to customise the site to your preferences and to receive alerts

    Register here

    Also in the molecular biology category:

    Blue light induces neuronal-activity-regulated gene expression in the absence of optogenetic proteins

    Kelsey M. Tyssowski, Jesse M. Gray

    Selected by Zheng-Shan Chong

    Slide-seq: A Scalable Technology for Measuring Genome-Wide Expression at High Spatial Resolution

    Samuel G Rodriques, Robert R Stickels, Aleksandrina Goeva, et al.


    High-density spatial transcriptomics arrays for in situ tissue profiling

    Sanja Vickovic, Goekcen Eraslan, Johanna Klughammer, et al.

    Selected by Carmen Adriaens

    Optical determination of absolute membrane potential

    Julia R. Lazzari-Dean, Anneliese M.M. Gest, Evan Miller

    Selected by James Marchant

    MicroRNA-mediated control of developmental lymphangiogenesis

    Hyun Min Jung, Ciara Hu, Alexandra M Fister, et al.

    Selected by Rudra Nayan Das

    Microfluidic protein isolation and sample preparation for high resolution cryo-EM

    Claudio Schmidli, Stefan Albiez, Luca Rima, et al.

    Selected by David Wright

    A DNA-based voltmeter for organelles

    Anand Saminathan, John Devany, Kavya S Pillai, et al.

    Selected by Robert Mahen


    Structures of the Otopetrin Proton Channels Otop1 and Otop3

    Kei Saotome, Bochuan Teng, Che Chun (Alex) Tsui, et al.

    Selected by David Wright

    Central spindle microtubules are strongly coupled to chromosomes during both anaphase A and anaphase B

    Che-Hang Yu, Stefanie Redemann, Hai-Yin Wu, et al.

    Selected by Federico Pelisch


    Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division

    Evgeny Zatulovskiy, Daniel F. Berenson, Benjamin R. Topacio, et al.

    Selected by Zaki Ahmad


    Distinct ROPGEFs successively drive polarization and outgrowth of root hairs

    Philipp Denninger, Anna Reichelt, Vanessa Aphaia Fiona Schmidt, et al.

    Selected by Marc Somssich

    Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells

    Jayashree Chadchankar, Victoria Korboukh, Peter Doig, et al.

    Selected by Mila Basic

    Bacteriophage resistance alters antibiotic mediated intestinal expansion of enterococci

    Anushila Chatterjee, Cydney N Johnson, Phat Luong, et al.

    Selected by Yasmin Lau

    On-site ribosome remodeling by locally synthesized ribosomal proteins in axons

    Toshiaki Shigeoka, Max Koppers, Hovy Ho-Wai Wong, et al.

    Selected by Srivats Venkataramanan

    MRE11-RAD50-NBS1 activates Fanconi Anemia R-loop suppression at transcription-replication conflicts

    Emily Yun-Chia Chang, James P Wells, Shu-Huei Tsai, et al.

    Selected by Katie Weiner


    Super-resolution Molecular Map of Basal Foot Reveals Novel Cilium in Airway Multiciliated Cells

    Quynh Nguyen, Zhen Liu, Rashmi Nanjundappa, et al.

    Selected by Robert Mahen

    Atlas of Subcellular RNA Localization Revealed by APEX-seq

    Furqan M Fazal, Shuo Han, Pornchai Kaewsapsak, et al.


    Proximity RNA labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

    Alejandro Padron, Shintaro Iwasaki, Nicholas Ingolia

    Selected by Christian Bates

    Also in the synthetic biology category:

    Blue light induces neuronal-activity-regulated gene expression in the absence of optogenetic proteins

    Kelsey M. Tyssowski, Jesse M. Gray

    Selected by Zheng-Shan Chong

    Aqueous synthesis of a small-molecule lanthanide chelator amenable to copper-free click chemistry

    Stephanie Cara Bishop, Robert Winefield, Asokan Anbanandam, et al.

    Selected by Zhang-He Goh

    Synthetic pluripotent bacterial stem cells

    Sara Molinari, David L. Shis, James Chappell, et al.

    Selected by Lorenzo Lafranchi

    A DNA-based voltmeter for organelles

    Anand Saminathan, John Devany, Kavya S Pillai, et al.

    Selected by Robert Mahen


    Variability of bacterial behavior in the mammalian gut captured using a growth-linked single-cell synthetic gene oscillator

    David T Riglar, David L Richmond, Laurent Potvin-Trottier, et al.

    Selected by Meng Zhu

    A direct selection strategy for isolating aptamers with pH-sensitive binding activity

    Chelsea K L Gordon, Michael Eisenstein, H T Soh

    Selected by Zhang-He Goh

    SABER enables highly multiplexed and amplified detection of DNA and RNA in cells and tissues

    Jocelyn Y. Kishi, Brian J. Beliveau, Sylvain W. Lapan, et al.

    Selected by Yen-Chung Chen

    LADL: Light-activated dynamic looping for endogenous gene expression control

    Mayuri Rege, Ji Hun Kim, Jacqueline Valeri, et al.

    Selected by Ivan Candido-Ferreira

    Glutamic acid is a carrier for hydrazine during the biosyntheses of fosfazinomycin and kinamycin

    Kwo-Kwang Abraham Wang, Tai L. Ng, Peng Wang, et al.

    Selected by Ellis O'Neill

    Super-Mendelian inheritance mediated by CRISPR/Cas9 in the female mouse germline

    Hannah A. Grunwald, Valentino M. Gantz, Gunnar Poplawski, et al.

    Selected by Rebekah Tillotson


    Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

    Kale Kundert, James E Lucas, Kyle E Watters, et al.

    Selected by Samantha Seah